Drug intelligence / Profile preview

arnica gel

Development stage: Unknown
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical, Oral

Overview

Arnica gel is a topical homeopathic preparation containing Arnica montana extract. It is primarily used to temporarily relieve muscle pain and stiffness due to minor injuries, reduce swelling, decrease pain from bruises, and treat inflammation. The active chemicals in arnica may reduce swelling, decrease pain, and act as antibiotics. Arnica gel works similarly to topical NSAIDs like diclofenac and ibuprofen.

Brand names: Arnica Gel
Other names: arnica montana gel

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NF-κBNFAT (NFAT family)

Beyond the preview

Go deeper on arnica gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on arnica gel.

Explore the full profile